Aktuelle Dermatologie 2009; 35(1/02): 49-57
DOI: 10.1055/s-2008-1077740
Fort- und Weiterbildung

© Georg Thieme Verlag KG Stuttgart · New York

Photodynamische Therapie

Photodynamic TherapyJ.  Steinbauer1 , S.  Karrer1 , M.  Landthaler1 , R.-M.  Szeimies1
  • 1Klinik und Poliklinik für Dermatologie, Universitätsklinikum Regensburg
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
29. Januar 2009 (online)

Dr. med. Julia Steinbauer

Literatur

  • 1 Tappeiner H. Über die Wirkung fluoreszierender Stoffe auf Infusorien nach Versuchen von Raab.  Münch Med Wochenschr. 1900;  1 5-7
  • 2 Dougherty T J, Kaufman J E, Goldfarb A. Photoradiation Therapy for the Treatment of Malignant Tumors.  Cancer Res. 1978;  38 2628-2635
  • 3 Kennedy J C, Pottier R H, Pross D C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.  J Photochem Photobiol B. 1990;  6 143-148
  • 4 Klein A, Babilas P, Karrer S, Landthaler M, Szeimies R M. Photodynamic Therapy in Dermatology – an Update 2008.  J Dtsch Dermatol Ges. 2008;  6 839-846
  • 5 Babilas P, Kohl E, Maisch T. et al . In vitro and in vivo comparison of two different light sources for topical photodynamic therapy.  Br J Dermatol. 2006;  154 712-718
  • 6 Babilas P, Knobler R, Hummel S. et al . Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial.  Br J Dermatol. 2007;  157 111-117
  • 7 Gold M H, Nestor M S. Current treatments of actinic keratosis.  J Drugs Dermatol. 2006;  5 (2 Suppl) 17-25
  • 8 Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer.  Br J Dermatol. 2007;  156 793-801
  • 9 Freeman M, Vinciullo C, Francis D. et al . A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study.  J Dermatolog Treat. 2003;  14 99-106
  • 10 Morton C, Campbell S, Gupta G. et al . Action Investigators. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.  Br J Dermatol. 2006;  155 1029-1036
  • 11 Wulf H C, Pavel S, Stender I. et al . Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients.  Acta Derm Venereol. 2006;  86 25-28
  • 12 Perrett C M, McGregor J M, Warwick J. et al . Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy.  Br J Dermatol. 2007;  156 320-328
  • 13 Rhodes L E, de Rie M, Enström Y. et al . Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.  Arch Dermatol. 2004;  140 17-23
  • 14 Szeimies R M, Ibbotson S, Murrel D F. et al .Randomised clinical trial of 5-aminolevulinata-photodynamic therapy (MAL-PDT) versus simple excision surgery for superficial basal cell carcinoma. Poster präsentiert auf der EADV-Konferenz, Wien, Mai 2007. 
  • 15 Rhodes L E, de Rie M A, Leifsdottir R. et al . Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs. surgery for nodular basal cell carcinoma.  Arch Dermatol. 2007;  143 1131-1136
  • 16 Telfer N R, Colver G B, Morton C A. Guidelines for the management of basal cell carcinoma.  Br J Dermatol. 2008;  159 35-48
  • 17 Salim A, Leman J A, McColl J H. et al . Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease.  Br J Dermatol. 2003;  148 539-543
  • 18 Morton C, Horn M, Leman J. et al . Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.  Arch Dermatol. 2006;  142 729-735
  • 19 Calzavara-Pinton P G, Venturini M, Sala R. et al . Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.  Br J dermatol. 2008;  159 137-144
  • 20 Mori M, Campolmi P, Mavilia L. et al . Topical photodynamic therapy for primary cutaneous B-cell lymphoma: a pilot study.  J Am Acad Dermatol. 2006;  54 524-526
  • 21 Hayami J, Okamoto H, Sugihara A. et al . Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid.  J Dermatol. 2007;  34 320-327
  • 22 Karrer S, Szeimies R M. Photodynamische Therapie nichtonkologischer Indikationen.  Hautarzt. 2007;  58 585-596
  • 23 Wiegell S R, Wulf H C. Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial.  Br J Dermatol. 2006;  154 969-976
  • 24 Stender I M, Na R, Fogh H. et al . Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial.  Lancet. 2000;  355 963-966
  • 25 Stefanaki I M, Georgiou S, Themelis G C. et al . In vivo fluorescence kinetics and photodynamic therapy in condylomata acuminata.  Br J Dermatol. 2003;  149 972-976
  • 26 Chen K, Chang B Z, Ju M. et al . Comparative study of photodynamic therapy vs CO2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial.  Br J Dermatol. 2007;  156 516-520
  • 27 Asilian A, Davami M. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial.  Clin Exp Dermatol. 2006;  31 634-637
  • 28 Touma D, Yaar M, Whitehead S. et al . A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage.  Arch Dermatol. 2004;  140 33-40
  • 29 Christiansen K, Bjerring P, Troilius A. 5-ALA for photodynamic photorejuvenation--optimization of treatment regime based on normal-skin fluorescence measurements.  Lasers Surg Med. 2007;  39 302-310
  • 30 Hauschild A, Szeimies R M. EADV Konferenz 16. – 20. 5. 2007 in Wien: Studie zu neuartigem 5-ALA-Pflaster (PD P 506 A).  J Dtsch Dermatol Ges. 2007;  5 815

Prof. Dr. med. Rolf-Markus Szeimies

Klinik und Poliklinik für Dermatologie
Universitätsklinikum Regensburg

Franz-Josef-Strauss-Allee 11
93053 Regensburg

eMail: Rolf-Markus.Szeimies@klinik.uni-r.de